Gene therapy involves the insertion of functional ADA gene into the lymphocytes of the patient. These cells are grown in vitro and returned to the patient’s body. This restores the ADA enzyme temporarily. Permanent cure: It can be achieved by introducing the functional gene into cells at the embryonic stage, ensuring a lifelong supply of ADA.